374145080	374145080	CD	B-NP	O
|	|	NN	I-NP	O
CMC	CMC	NN	I-NP	O
|	|	NN	I-NP	O
37710772	37710772	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7613746	7613746	CD	B-NP	O
|	|	CC	I-NP	O
2/22/2007	2/22/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
;	;	:	O	O
hemoptysis	hemoptysis	NN	B-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/16/2007	11/16/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/3/2007	9/3/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
CRUMMEY	CRUMMEY	NN	I-NP	O
,	,	,	O	O
JR	JR	NNP	B-NP	O
,	,	,	O	O
OSCAR	OSCAR	NNP	B-NP	O
528-81-05-2	528-81-05-2	CD	I-NP	O
Ni	Ni	NNP	I-NP	O
Blvd.	Blvd.	NNP	I-NP	O
,	,	,	O	O
Co	Co	NNP	B-NP	O
,	,	,	O	O
Montana	Montana	NNP	B-NP	O
90711	90711	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
8/29/07	8/29/07	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LANAGAN	LANAGAN	NN	B-NP	O
,	,	,	O	O
IRWIN	IRWIN	NNP	B-NP	O
ANGELO	ANGELO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

ALENDRONATE	ALENDRONATE	RB	B-NP	O
70	70	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QWEEK	QWEEK	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

ATORVASTATIN	ATORVASTATIN	IN	B-PP	O
40	40	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEMENTAL	ELEMENTAL	NN	I-NP	O
CA	CA	NN	I-NP	O
+	+	SYM	B-VP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	O
1250	1250	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

CYCLOSPORINE	CYCLOSPORINE	NN	B-NP	O
MICRO	MICRO	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NEORAL	NEORAL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

DILTIAZEM	DILTIAZEM	NN	B-NP	B-protein
CD	CD	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
24	24	CD	I-NP	I-protein
HR	HR	NN	I-NP	I-protein
CAPS	CAPS	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

DOXAZOSIN	DOXAZOSIN	NN	B-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

MAGNESIUM	MAGNESIUM	NN	B-NP	B-protein
OXIDE	OXIDE	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
241	241	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
ELEMENTAL	ELEMENTAL	NNP	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
400	400	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
11	11	CD	I-NP	I-protein
.	.	.	O	O

NIFEREX	NIFEREX	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

PREDNISONE	PREDNISONE	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QAM	QAM	NNP	B-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

SIROLIMUS	SIROLIMUS	NN	B-NP	O
2	2	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	B-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

METOPROLOL	METOPROLOL	NNP	B-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/12/07	1/12/07	CD	B-NP	O
by	by	IN	B-PP	O
ROMIE	ROMIE	NNP	B-NP	O
,	,	,	O	O
JOAQUIN	JOAQUIN	NNP	B-NP	O
O.	O.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
149904062	149904062	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
DEFINITE	DEFINITE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Aspirin	Aspirin	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
orbital	orbital	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
desensitization	desensitization	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
needs	need	VBZ	B-VP	O
aspirin	aspirin	NN	B-NP	O
given	give	VBN	I-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

home	home	NN	B-NP	O
med	me	VBD	B-VP	O
.	.	.	O	O

FOSAMAX	FOSAMAX	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ALENDRONATE	ALENDRONATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
70	70	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Take	Take	NN	I-NP	O
with	with	IN	B-PP	O
8	8	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
plain	plain	JJ	B-NP	O
water	water	NN	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/29/07	8/29/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
ALENDRONATE	ALENDRONATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/29/07	8/29/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEMENTAL	ELEMENTAL	NN	I-NP	O
CA	CA	NN	I-NP	O
+	+	SYM	B-VP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	O
500	500	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	B-DNA
-RRB-	-RRB-	HYPH	B-NP	I-DNA
75	75	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
DAILY	DAILY	NN	I-NP	I-DNA
NEORAL	NEORAL	NN	I-NP	I-DNA
CYCLOSPORINE	CYCLOSPORINE	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
CYCLOSPORINE	CYCLOSPORINE	NN	I-NP	I-DNA
MICRO	MICRO	NN	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
NEORAL	NEORAL	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/16/07	5/16/07	CD	B-NP	O
by	by	IN	B-PP	O
ANNABEL	ANNABEL	NNP	B-NP	O
,	,	,	O	O
LESLEY	LESLEY	NNP	B-NP	O
RONNY	RONNY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
QHS	QHS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
620856181	620856181	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/8/07	8/8/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Previous	Previous	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/8/07	8/8/07	CD	B-NP	O
by	by	IN	B-PP	O
BUGBEE	BUGBEE	NNP	B-NP	O
,	,	,	O	O
CRUZ	CRUZ	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
430842588	430842588	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/12/07	1/12/07	CD	B-NP	O
by	by	IN	B-PP	O
RAFALSKI	RAFALSKI	NN	B-NP	O
,	,	,	O	O
DELBERT	DELBERT	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

home	home	NN	B-NP	O
med	me	VBD	B-VP	O
.	.	.	O	O

DILTIAZEM	DILTIAZEM	NN	B-NP	O
CD	CD	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
24	24	CD	I-NP	O
HR	HR	NN	I-NP	O
CAPS	CAPS	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/29/07	8/29/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

home	home	NN	B-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

CARDURA	CARDURA	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
DOXAZOSIN	DOXAZOSIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
\	\	VB	B-VP	O
NEXIUM	NEXIUM	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/9	1/9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
OH	OH	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	B-protein
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
EVERY	EVERY	NNP	I-NP	I-protein
OTHER	OTHER	NNP	I-NP	I-protein
DAY	DAY	NNP	I-NP	I-protein
X	X	NNP	I-NP	I-protein
8	8	CD	I-NP	I-protein
Days	Days	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
5/3	5/3	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
last	last	JJ	B-NP	O
day	day	NN	I-NP	O
6/2/07	6/2/07	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/8/07	8/8/07	CD	B-NP	O
by	by	IN	B-PP	O
WENDT	WENDT	NNP	B-NP	O
,	,	,	O	O
SALVATORE	SALVATORE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POLYSACCHARIDE	POLYSACCHARIDE	NNP	B-NP	O
IRON	IRON	NNP	I-NP	O
COMPLEX	COMPLEX	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
MAGNESIUM	MAGNESIUM	NN	I-NP	O
OXIDE	OXIDE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
241	241	CD	I-NP	O
MG	MG	NNP	I-NP	O
ELEMENTAL	ELEMENTAL	NNP	I-NP	O
MG	MG	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
400	400	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/29/07	8/29/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

home	home	NN	B-NP	O
med	me	VBD	B-VP	O
.	.	.	O	O

NIFEREX	NIFEREX	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/8/07	8/8/07	CD	B-NP	O
by	by	IN	B-PP	O
CRAIGHEAD	CRAIGHEAD	NNP	B-NP	O
,	,	,	O	O
SHELDON	SHELDON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
393016310	393016310	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	I-protein
SERIOUS	SERIOUS	NNP	I-NP	I-protein
INTERACTION	INTERACTION	NNP	I-NP	I-protein
:	:	:	O	I-protein
POLYSACCHARIDE	POLYSACCHARIDE	NNP	B-NP	I-protein
IRON	IRON	NNP	I-NP	I-protein
COMPLEX	COMPLEX	NNP	I-NP	I-protein
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
PREDNISONE	PREDNISONE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
use	use	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Lugones	Lugones	NNP	I-NP	O
-	-	HYPH	B-NP	O
please	please	NN	I-NP	O
call	call	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Cardiac	Cardiac	NNP	B-NP	O
Transplant	Transplant	NNP	I-NP	O
,	,	,	O	O
RH	RH	NNP	B-NP	O
Dera	Dera	NNP	I-NP	O
ph	ph	NN	I-NP	O
051-469-9935	051-469-9935	CD	I-NP	O
1/12/07	1/12/07	CD	I-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
am	am	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Hirose	Hirose	NNP	I-NP	O
,	,	,	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
,	,	,	O	O
RSCH	RSCH	NNP	B-NP	O
Ponce	Ponce	NNP	I-NP	O
,	,	,	O	O
Utah	Utah	NNP	B-NP	O
01302	01302	CD	I-NP	O
ph	ph	NN	I-NP	O
234-865-1925	234-865-1925	CD	B-NP	O
9/9/07	9/9/07	CD	I-NP	O
at	at	IN	B-PP	O
1pm	1pm	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
PET	PET	NN	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
-	-	HYPH	B-NP	O
BEFORE	BEFORE	NN	I-NP	O
YOUR	YOUR	NN	I-NP	O
PULMONARY	PULMONARY	NN	I-NP	O
APPT	APPT	NN	I-NP	O
-	-	HYPH	B-NP	O
PLEASE	PLEASE	NNP	I-NP	O
GO	GO	NNP	I-NP	O
TO	TO	NNP	I-NP	O
Greencam	Greencam	NNP	I-NP	O
Lu	Lu	NNP	I-NP	O
Ge	Ge	NNP	I-NP	O
at	at	IN	B-PP	O
Sgogrove	Sgogrove	NNP	B-NP	O
Faysonco	Faysonco	NNP	I-NP	O
,	,	,	O	O
NUCLEAR	NUCLEAR	NNP	B-NP	O
MEDICINE	MEDICINE	NNP	I-NP	O
9/9/07	9/9/07	CD	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
am	am	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
,	,	,	O	O
PROCAINAMIDE	PROCAINAMIDE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
ACE	ACE	NNP	B-NP	O
Inhibitor	Inhibitor	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
;	;	:	O	O
hemoptysis	hemoptysis	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
1997	1997	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
allograft	allograft	NN	B-NP	O
vasculopathy	vasculopathy	NN	I-NP	O
-	-	HYPH	B-NP	O
MI	MI	NN	I-NP	O
sp	sp	NN	I-NP	O
PCI	PCI	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
in	in	IN	B-PP	O
10/24	10/24	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
h/o	h/o	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
and	and	CC	I-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
11/12	11/12	CD	I-NP	O
lung	lung	NN	I-NP	O
mass	mass	NN	I-NP	O
v	v	NN	I-NP	O
atelectatic	atelectatic	JJ	I-NP	O
lung	lung	NN	I-NP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	O
;	;	:	O	O
claudication	claudication	NN	B-NP	O
;	;	:	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
;	;	:	O	O
HTN	HTN	NN	B-NP	B-protein
;	;	:	O	O
nasal	nasal	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Bronchoscopy	Bronchoscopy	NNP	B-NP	O
11/8/07	11/8/07	CD	I-NP	O
:	:	:	O	O
active	active	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
from	from	IN	B-PP	O
RML	RML	NN	B-NP	O
bronchus	bronchus	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
prevented	prevent	VBD	B-VP	O
visualization	visualization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
subsegments	subsegment	NNS	I-NP	O
or	or	CC	I-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bronchus	bronchus	NN	I-NP	O
.	.	.	O	O

BAL	BAL	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RML	RML	NN	I-NP	O
orifice	orifice	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
achieved	achieve	VBN	I-VP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Adjustment	Adjustment	NNP	I-NP	O
of	of	IN	B-PP	O
immune	immune	JJ	B-NP	O
suppressants	suppressant	NNS	I-NP	O
,	,	,	O	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
,	,	,	O	O
empiric	empiric	JJ	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
.	.	.	O	O

LENIs	LENI	NNS	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
***	***	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
58yo	58yo	CD	B-NP	O
M	M	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
ischemic	ischemic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
s/p	s/p	NN	I-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
1997	1997	CD	I-NP	O
c/b	c/b	NN	I-NP	O
allograft	allograft	NN	I-NP	O
vasculopathy	vasculopathy	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
LAD	LAD	NN	I-NP	O
stent	stent	NN	I-NP	O
10/24	10/24	CD	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
desensitization	desensitization	NN	I-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
hemorrhage/PNA	hemorrhage/PNA	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
hemoptysis	hemoptysis	NN	B-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
past	past	JJ	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
developed	develop	VBN	B-VP	O
ST	ST	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
increasing	increase	VBG	B-VP	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
wheezing	wheeze	VBG	B-VP	O
and	and	CC	I-VP	O
worsening	worsen	VBG	I-VP	O
DOE	DOE	NNP	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
leg	leg	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
F/C	F/C	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
epistaxis	epistaxis	NN	I-NP	O
.	.	.	O	O

Seen	Seen	NN	B-NP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
today	today	NN	B-NP	O
,	,	,	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
89	89	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
RLE	RLE	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
afeb	afeb	NN	B-NP	O
,	,	,	O	O
P95	P95	NN	B-NP	B-protein
,	,	,	O	O
165/82	165/82	CD	B-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
baseline	baseline	NN	I-NP	I-protein
92-93	92-93	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

PE-CT	PE-CT	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
IVFs	IVF	NNS	I-NP	B-protein
but	but	CC	O	O
then	then	RB	B-ADVP	O
diuresed	diurese	VBN	B-VP	O
.	.	.	O	O

***	***	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
CABG	CABG	NN	B-NP	O
1990	1990	CD	I-NP	O
,	,	,	O	O
iCMP	iCMP	NN	B-NP	O
s/p	s/p	NN	I-NP	O
transplant	transplant	NN	I-NP	O
1997	1997	CD	I-NP	O
c/b	c/b	NN	I-NP	O
allograph	allograph	NN	I-NP	O
vasculopathy	vasculopathy	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
biopsy	biopsy	NN	B-NP	O
11/29	11/29	CD	I-NP	O
neg	neg	NN	I-NP	O
for	for	IN	B-PP	O
rejection	rejection	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
LAD	LAD	NN	I-NP	O
stent	stent	NN	I-NP	O
10/24	10/24	CD	I-NP	O
,	,	,	O	O
claudication	claudication	NN	B-NP	O
,	,	,	O	O
diet	diet	NN	B-NP	O
controlled	control	VBD	B-VP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
nasal	nasal	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
procainamide	procainamide	NN	B-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
desensitized	desensitize	VBD	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
***	***	NN	I-NP	O
Admission	Admission	NNP	I-NP	O
EXAM	EXAM	NNP	I-NP	O
:	:	:	O	O
Afeb	Afeb	NN	B-NP	O
,	,	,	O	O
P90	P90	NN	B-NP	B-protein
,	,	,	O	O
142/70	142/70	CD	B-NP	O
,	,	,	I-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
92-93	92-93	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
Tachypneic	Tachypneic	NNP	I-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
BS	BS	NNP	B-NP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
no	no	DT	B-NP	O
M/G/R	M/G/R	NN	I-NP	B-protein
,	,	,	O	O
prominent	prominent	JJ	B-NP	O
PMI	PMI	NN	I-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
bengin	bengin	NN	I-NP	O
,	,	,	O	O
LLE	LLE	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
RLE	RLE	NN	B-NP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
bilat	bilat	NN	I-NP	O
,	,	,	O	O
warm	warm	JJ	B-NP	O
ext	ext	NN	I-NP	O
***	***	SYM	B-NP	O
STUDIES	STUDIES	NN	I-NP	O
Creat	Creat	NNP	B-NP	O
1.7	1.7	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
baseline	baseline	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
Hct	Hct	NN	B-NP	B-protein
31	31	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
stable	stable	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ABG	ABG	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
7.45	7.45	CD	I-NP	I-protein
/	/	SYM	I-NP	O
34/63	34/63	CD	I-NP	O
*	*	SYM	I-NP	O
EKG	EKG	NN	I-NP	B-protein
7/10	7/10	CD	I-NP	I-protein
NSR	NSR	NN	I-NP	I-protein
,	,	,	O	O
1st	1st	JJ	B-NP	B-protein
degree	degree	NN	I-NP	I-protein
AVB	AVB	NN	I-NP	I-protein
,	,	,	O	O
nonspecific	nonspecific	JJ	B-NP	O
ST-T	ST-T	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
*	*	SYM	I-NP	O
PE-CT	PE-CT	NN	I-NP	O
10/26	10/26	CD	I-NP	O
No	No	DT	B-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O
?	?	.	O	O

Filling	Fill	VBG	B-VP	O
defect	defect	NN	B-NP	O
in	in	IN	B-PP	O
distal	distal	JJ	B-NP	O
SVC	SVC	NN	I-NP	O
vs	vs	IN	B-PP	O
IVC	IVC	NN	B-NP	B-protein
.	.	.	O	O

New	New	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
eff	eff	NN	I-NP	O
,	,	,	O	O
stable	stable	JJ	B-NP	O
cardiomeg	cardiomeg	NN	I-NP	O
,	,	,	O	O
new	new	JJ	B-NP	O
fibrotic	fibrotic	JJ	I-NP	O
changes	change	NNS	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
,	,	,	O	O
diffuse	diffuse	JJ	B-NP	O
ground	ground	NN	I-NP	O
glass	glass	NN	I-NP	O
opacities	opacity	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
pulm	pulm	NN	B-NP	B-protein
edema	edema	NN	I-NP	I-protein
vs	vs	IN	B-PP	I-protein
PNA	PNA	NN	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
*	*	SYM	O	O
TTE	TTE	NNP	B-NP	O
October	October	NNP	I-NP	O
2007	2007	CD	I-NP	O
-	-	HYPH	B-NP	O
EF	EF	NN	I-NP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
rWMAs	rWMAs	NN	B-NP	O
*	*	SYM	B-NP	O
R	R	NN	I-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
October	October	NNP	B-NP	O
2007	2007	CD	I-NP	O
-	-	HYPH	B-NP	O
Wedge	Wedge	NN	I-NP	O
12	12	CD	I-NP	O
***	***	SYM	I-NP	O
daily	daily	JJ	I-NP	O
events	event	NNS	I-NP	O
:	:	:	O	O
11/5	11/5	CD	B-NP	O
neg	neg	NN	I-NP	O
LENIs	LENI	NNS	I-NP	O
,	,	,	O	O
pulm	pulm	NN	B-NP	B-protein
consult	consult	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
fellow	fellow	JJ	I-NP	I-protein
Dellwo	Dellwo	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
,	,	,	O	O
had	have	VBD	B-VP	O
echo	echo	JJ	B-ADJP	O
,	,	,	O	O
getting	get	VBG	B-VP	O
sputum	sputum	NN	B-NP	O
9/17	9/17	CD	I-NP	O
some	some	DT	B-NP	O
neck	neck	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
maybe	maybe	RB	B-ADVP	O
from	from	IN	B-PP	O
Mucomyst	Mucomyst	NNP	B-NP	O
,	,	,	O	O
dced	dce	VBD	B-VP	O
Mucomyst	Mucomyst	NNP	B-NP	O
,	,	,	O	O
now	now	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
checking	check	VBG	B-VP	O
sputum	sputum	NN	B-NP	O
for	for	IN	B-PP	O
PCP	PCP	NN	B-NP	B-DNA
2/12	2/12	CD	I-NP	I-DNA
improved	improve	VBD	B-VP	O
neck	neck	NN	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
ambulatory	ambulatory	JJ	I-NP	O
sats	sat	NNS	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nl	nl	NN	B-NP	B-protein
HRs	HR	NNS	I-NP	I-protein
in	in	IN	B-PP	O
80s	80s	CD	B-NP	O
1/24	1/24	CD	I-NP	O
Bronch	Bronch	NNP	I-NP	O
showed	show	VBD	B-VP	O
active	active	JJ	B-NP	O
RML	RML	NN	I-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
bronchial	bronchial	JJ	B-NP	O
washings	washing	NNS	I-NP	O
performed	perform	VBN	B-VP	O
,	,	,	O	O
fluid	fluid	NN	B-NP	O
sent	send	VBD	B-VP	O
for	for	IN	B-PP	O
micro	micro	NN	B-NP	O
***	***	SYM	B-NP	O
Discharge	Discharge	NN	I-NP	O
physical	physical	JJ	I-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
afebrile	afebrile	JJ	B-NP	O
,	,	,	I-NP	O
HR	HR	NN	I-NP	B-cell_line
80s-100s	80s-100	NNS	I-NP	I-cell_line
,	,	,	O	O
bp	bp	NN	B-NP	O
120s-130s	120s-130s	CD	I-NP	O
/	/	SYM	B-NP	O
60s-80s	60s-80s	CD	I-NP	O
,	,	,	O	O
94-95	94-95	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

Ambulatory	Ambulatory	JJ	B-NP	O
O2	O2	NN	I-NP	O
sat	sit	VBD	B-VP	O
87	87	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

comfortable	comfortable	JJ	B-NP	O
NAD	NAD	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
decreased	decrease	VBD	B-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
RRR	RRR	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs/rubs/gallops	murmurs/rubs/gallop	NNS	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Abd	Abd	NN	B-NP	O
soft	soft	JJ	B-ADJP	O
.	.	.	O	O

Ext	Ext	NN	B-NP	O
LLE	LLE	NN	I-NP	O
trace	trace	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
RLE	RLE	NN	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Warm	Warm	NNP	B-NP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

*******	*******	SYM	B-NP	O
IMPRESSION	IMPRESSION	NN	I-NP	O
:	:	:	O	O
58yo	58yo	CD	B-NP	O
M	M	NN	I-NP	O
s/p	s/p	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
c/b	c/b	NN	I-NP	O
allograft	allograft	NN	I-NP	O
vasculopathy	vasculopathy	NN	I-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
admission	admission	NN	I-NP	O
in	in	IN	B-PP	O
10/6	10/6	CD	B-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
hemorrhage/PNA	hemorrhage/PNA	NN	I-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
SOB	SOB	NN	I-NP	B-protein
and	and	CC	I-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
.	.	.	O	O

Likely	Likely	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
+	+	SYM	B-NP	O
/	/	SYM	B-NP	B-protein
-	-	SYM	I-NP	I-protein
ILD	ILD	NN	I-NP	I-protein
+	+	SYM	B-NP	O
/	/	SYM	B-VP	O
-	-	HYPH	B-NP	O
PNA	PNA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CAP	CAP	NN	I-NP	O
,	,	,	O	O
atypicals	atypical	NNS	B-NP	O
,	,	,	O	O
TB	TB	NN	B-NP	B-protein
,	,	,	O	O
PCP	PCP	NN	B-NP	B-protein
,	,	,	O	O
fungal	fungal	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
's	's	POS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

However	However	RB	B-NP	O
bronchoscopy	bronchoscopy	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
RML	RML	NN	B-NP	O
fresh	fresh	JJ	I-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CT	CT	NN	B-NP	O
chest	chest	NN	I-NP	O
is	be	VBZ	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
RML	RML	NN	B-NP	O
mass	mass	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	O	O
need	need	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
already	already	RB	I-VP	O
arranged	arrange	VBN	I-VP	O
.	.	.	O	O

1	1	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

CV	CV	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
continued	continue	VBD	B-VP	O
outpatient	outpatient	NN	B-NP	O
ASA	ASA	NN	I-NP	O
,	,	,	O	O
bblocker	bblocker	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
.	.	.	O	O

H/o	H/o	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

Cyclosporine	Cyclosporine	NN	B-NP	O
level	level	NN	I-NP	O
on	on	IN	B-PP	O
10/27	10/27	CD	B-NP	O
was	be	VBD	B-VP	O
152	152	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cyclosporine	cyclosporine	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
100mg	100mg	CD	B-NP	O
po	po	NN	I-NP	O
BID	BID	NNP	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
sirolimus	sirolimus	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

PUMP	PUMP	NN	B-NP	B-protein
-	-	HYPH	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
intially	intially	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBN	B-VP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
674	674	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	O
40mg	40mg	CD	I-NP	O
po	po	NN	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	B-protein
40mg	40mg	CD	I-NP	I-protein
po	po	NN	I-NP	I-protein
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
given	give	VBN	B-PP	O
potassium	potassium	NN	B-NP	O
10meq	10meq	CD	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
lytes	lyte	NNS	B-NP	O
followed	follow	VBN	B-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
HCTZ	HCTZ	NN	I-NP	B-protein
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Weight	Weight	NN	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
62.2	62.2	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

BP	BP	NN	B-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
dilt	dilt	NN	B-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
,	,	,	O	O
cadura	cadura	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
bronchoscopy	bronchoscopy	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
described	describe	VBN	I-VP	O
above	above	IN	B-PP	O
-LRB-	-LRB-	JJ	B-NP	O
fresh	fresh	JJ	I-NP	O
blood	blood	NN	I-NP	O
oozing	ooze	VBG	B-VP	O
from	from	IN	B-PP	O
RML	RML	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

BAL	BAL	NN	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
influenza	influenza	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
adeno	adeno	AFX	B-NP	O
negative	negative	JJ	I-NP	O
,	,	,	I-NP	O
viral	viral	JJ	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
cultures	culture	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cytology	cytology	NN	B-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Galact	Galact	NN	B-NP	B-protein
Ag	Ag	NN	I-NP	I-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

GBM	GBM	NN	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

ANCA	ANCA	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O

Bronchoscopy	Bronchoscopy	NNP	B-NP	O
and	and	CC	O	O
chest	chest	NN	B-NP	O
CT	CT	NN	I-NP	O
were	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
RML	RML	NN	B-NP	O
mass	mass	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PET	PET	NN	I-NP	B-protein
CT	CT	NN	I-NP	I-protein
and	and	CC	O	O
Pulmonary	Pulmonary	JJ	B-NP	O
appointment	appointment	NN	I-NP	O
on	on	IN	B-PP	O
9/2/07	9/2/07	CD	B-NP	O
.	.	.	O	O

Allergy	Allergy	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
re	re	NN	B-NP	O
whether	whether	IN	B-SBAR	O
his	his	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
allergic	allergic	JJ	I-NP	O
pneumonitis	pneumonitis	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
given	give	VBN	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
ASA	ASA	NN	B-NP	O
allergy	allergy	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
previous	previous	JJ	I-NP	O
desensitization	desensitization	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
they	they	PRP	B-NP	O
felt	feel	VBD	B-VP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
.	.	.	O	O

Rheumatology	Rheumatology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
re	re	IN	B-PP	O
possible	possible	JJ	B-NP	O
vasculitis	vasculitis	NN	I-NP	O
given	give	VBN	B-VP	O
new	new	JJ	B-NP	O
proteinuria	proteinuria	NN	I-NP	O
-	-	HYPH	O	O
thought	think	VBN	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
although	although	IN	B-SBAR	O
final	final	JJ	B-NP	O
consult	consult	NN	I-NP	O
recommendations	recommendation	NNS	I-NP	O
were	be	VBD	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
given	give	VBN	B-VP	O
desat	desat	NN	B-NP	O
to	to	TO	B-PP	O
87	87	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
empirically	empirically	RB	B-ADVP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
x	x	SYM	O	O
14	14	CD	B-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
to	to	TO	B-VP	O
finish	finish	VB	I-VP	O
on	on	IN	B-PP	O
6/2/07	6/2/07	CD	B-NP	O
in	in	IN	B-PP	O
case	case	NN	B-NP	O
mass	mass	NN	I-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
RML	RML	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
infectious	infectious	JJ	B-NP	O
.1	.1	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
LENIs	LENI	NNS	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

has	have	VBZ	O	O
iron	iron	NN	B-NP	O
defiency	defiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
.	.	.	O	O

4	4	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
,	,	,	O	O
diet	diet	NN	B-NP	O
controlled	control	VBN	B-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

renal	renal	JJ	B-ADJP	O
:	:	:	O	O
proteinuria	proteinuria	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
explanation	explanation	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
further	further	RB	B-ADVP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

baseline	baseline	NN	B-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Osweneer	Osweneer	NN	B-NP	O
And	And	CC	O	O
Hospital	Hospital	NN	B-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
furosemide	furosemide	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
lasix	lasix	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
your	your	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
has	have	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
need	need	VB	I-VP	O
oxygen	oxygen	NN	B-NP	O
when	when	WRB	B-ADVP	O
you	you	PRP	B-NP	O
walk	walk	VBP	B-VP	O
or	or	CC	I-VP	O
exert	exert	VBP	I-VP	O
yourself	yourself	PRP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
which	which	WDT	B-NP	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
use	use	VB	I-VP	O
whenever	whenever	WRB	B-ADVP	O
you	you	PRP	B-NP	O
walk	walk	VBP	B-VP	O
or	or	CC	O	O
exert	exert	VB	B-VP	O
yourself	yourself	PRP	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
bronchoscopy	bronchoscopy	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
some	some	DT	B-NP	O
blood	blood	NN	I-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lung	lung	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pulmologist	pulmologist	NN	I-NP	O
regarding	regard	VBG	B-VP	O
this	this	DT	B-NP	O
finding	finding	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
keep	keep	VBP	B-VP	O
your	your	PRP$	B-NP	O
appointment	appointment	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
PET	PET	NN	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
on	on	IN	B-PP	O
10/27	10/27	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
appointment	appointment	NN	I-NP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
pulmonologist	pulmonologist	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
also	also	RB	B-ADVP	O
have	have	VBP	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
service	service	NN	I-NP	O
here	here	RB	B-ADVP	O
at	at	IN	B-PP	O
OTMC	OTMC	NN	B-NP	B-protein
on	on	IN	B-PP	O
3/15	3/15	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
keep	keep	VBP	B-VP	O
that	that	IN	B-SBAR	O
appointment	appointment	NN	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
and	and	CC	O	O
arrange	arrange	NN	B-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
him	him	PRP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
week	week	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
several	several	JJ	B-NP	O
changes	change	NNS	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
include	include	VBP	B-VP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
STOP	STOP	NNP	I-NP	O
YOUR	YOUR	NNP	I-NP	O
SIROLIMUS	SIROLIMUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
rapamune	rapamune	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
INCREASE	INCREASE	NN	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NN	I-NP	O
to	to	TO	B-VP	O
100mg	100mg	VB	I-VP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
you	you	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
50mg	50mg	CD	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
STOP	STOP	NN	I-NP	B-protein
YOUR	YOUR	NN	I-NP	I-protein
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
START	START	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LASIX	LASIX	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
diuretic	diuretic	JJ	I-NP	O
,	,	,	I-NP	O
40mg	40mg	CD	I-NP	O
once	once	RB	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
START	START	NNP	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
take	take	VB	B-VP	O
one	one	CD	B-NP	O
pill	pill	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
fourteen	fourteen	JJ	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
last	last	JJ	B-NP	O
day	day	NN	I-NP	O
6/2/07	6/2/07	CD	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
START	START	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
10mEq	10mEq	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CONTINUE	CONTINUE	NN	I-NP	O
YOUR	YOUR	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
YOU	YOU	PRP	B-NP	O
WILL	WILL	MD	B-VP	O
HAVE	HAVE	VB	I-VP	O
VISITING	VISITING	VBG	I-VP	O
NURSES	NURSES	NNS	B-NP	O
COME	COME	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
house	house	NN	I-NP	O
to	to	TO	B-VP	O
assist	assist	VB	I-VP	O
you	you	PRP	B-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
,	,	,	O	O
medication	medication	NN	B-NP	O
checks	check	NNS	I-NP	O
and	and	CC	O	O
teaching	teaching	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
safety	safety	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
check	check	VB	I-VP	O
your	your	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
specifically	specifically	RB	B-VP	O
monitor	monitor	VB	I-VP	O
your	your	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
magnesium	magnesium	NN	B-NP	O
with	with	IN	B-PP	O
reports	report	NNS	B-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
who	who	WP	B-NP	O
can	can	MD	B-VP	O
adjust	adjust	VB	I-VP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
seek	seek	VB	I-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
again	again	RB	B-ADVP	O
develop	develop	VBP	B-VP	O
any	any	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
coughing	cough	VBG	B-VP	O
up	up	RP	B-PRT	O
blood	blood	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
or	or	CC	I-NP	O
fainting	fainting	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
follow	follow	VBP	B-VP	O
cyclosporine	cyclosporine	NN	B-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
Sirolimus	Sirolimus	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
rheumatoid	rheumatoid	JJ	B-NP	O
factor	factor	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	O
serologies	serology	NNS	I-NP	O
,	,	,	O	O
ANCA	ANCA	NN	B-NP	B-protein
,	,	,	O	O
CH50	CH50	NN	B-NP	B-protein
,	,	,	O	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
proteinuria	proteinuria	NN	B-NP	O
,	,	,	O	O
BAL	BAL	NN	B-NP	O
viral	viral	JJ	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
BAL	BAL	NN	B-NP	B-protein
cultures	culture	NNS	I-NP	I-protein
3	3	CD	B-NP	I-protein
-RRB-	-RRB-	HYPH	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
BAL	BAL	NN	B-NP	B-protein
cytology	cytology	NN	I-NP	I-protein
4	4	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
mass	mass	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
oozing	ooze	VBG	B-VP	O
on	on	IN	B-PP	O
bronchoscopy	bronchoscopy	NN	B-NP	O
from	from	IN	B-PP	O
RML	RML	NN	B-NP	B-protein
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
PET	PET	NN	I-NP	B-protein
CT	CT	NN	I-NP	I-protein
scheduled	schedule	VBN	B-VP	O
for	for	IN	B-PP	O
10/27	10/27	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
Pulmonary	Pulmonary	JJ	B-NP	O
clinic	clinic	NN	I-NP	O
10/27	10/27	CD	I-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
complete	complete	JJ	I-NP	O
empiric	empiric	JJ	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
course	course	NN	I-NP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
last	last	JJ	B-NP	O
day	day	NN	I-NP	O
6/2/07	6/2/07	CD	B-NP	O
LABS	LABS	NN	I-NP	O
onday	onday	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
K	K	NN	I-NP	O
3.5	3.5	CD	I-NP	O
-LRB-	-LRB-	HYPH	O	O
given	give	VBN	B-NP	O
potassium	potassium	NN	I-NP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
1.9	1.9	CD	I-NP	O
,	,	,	O	O
Mg	Mg	NNP	B-NP	O
1.9	1.9	CD	I-NP	O
.	.	.	O	O

Hct	Hct	NN	B-NP	O
27.5	27.5	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BRAMLEY	BRAMLEY	NNP	B-NP	O
,	,	,	O	O
HUEY	HUEY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SC914	SC914	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
8/29/07	8/29/07	CD	I-NP	O
@	@	SYM	I-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

